nr. 1153 Conclusions Signalling networks are essential elements that are involved in diverse cellular processes. One group of fundamental components in various signalling pathways concerns protein tyrosine kinases (PTKs). PTK are of widespread interest not only because of their intrinsic physiological functions and being drug targets in the treatment of malignant diseases, but also
because of their role in the toxicity of various (immuno-)toxicants. In a previous study we assessed the effects of a wide range of compounds on the transcriptome of the human Jurkat T-cell line in vitro to identify common mechanisms underlying direct immunotoxicity (Shao et al. 2013 , Toxicol Sci. 135 (2):328-346). The present work aimed to identify cellular signalling pathways that are commonly modulated by immunotoxicants at the protein phosphorylation level. • The antibody array study showed that phosphorylation of RPS6, the kinases Akt, Src, and p44/42 is affected by at least three of the immunotoxicants and immuno-suppressive drugs, with the largest effect observed for RPS6 which is part of the mTOR-p70S6K-RPS6 pathway (Fig. 2) . • Western blotting revealed that both TBTO and the mTOR inhibitor rapamycin inactivate RPS6 but via different mechanisms (Fig. 3 ).
• Comparison of protein phosphorylation to transcriptome data resulted in a good correlation at the pathway level and indicated that TBTO affects ribosome biogenesis and leukocyte migration (Fig. 4) • TBTO affects the kinase p70S6K (upstream regulator of RPS6) but via a different mechanism than the immunosuppressive drug and mTOR inhibitor rapamycin.
• TBTO decreases CXCL12-mediated chemotaxis of Jurkat cells. 
